mebendazole has been researched along with Central Nervous System Diseases in 3 studies
Mebendazole: A benzimidazole that acts by interfering with CARBOHYDRATE METABOLISM and inhibiting polymerization of MICROTUBULES.
mebendazole : A carbamate ester that is methyl 1H-benzimidazol-2-ylcarbamate substituted by a benzoyl group at position 5.
Central Nervous System Diseases: Diseases of any component of the brain (including the cerebral hemispheres, diencephalon, brain stem, and cerebellum) or the spinal cord.
Excerpt | Relevance | Reference |
---|---|---|
"Mebendazole was started immediately after surgery and continued over 12 months." | 1.30 | The role of mebendazole in the surgical treatment of central nervous system hydatid disease. ( Babuna, O; Canbaz, B; Erdinçler, P; Kaynar, MY, 1997) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Erdinçler, P | 1 |
Kaynar, MY | 1 |
Babuna, O | 1 |
Canbaz, B | 1 |
Mittermayer, T | 1 |
Cisárová, A | 1 |
Carnická, A | 1 |
Magyar, B | 1 |
Maloveská, M | 1 |
Schréter, I | 1 |
Todorov, T | 1 |
Vutova, K | 1 |
Mechkov, G | 1 |
Georgiev, P | 1 |
Petkov, D | 1 |
Tonchev, Z | 1 |
Nedelkov, G | 1 |
3 other studies available for mebendazole and Central Nervous System Diseases
Article | Year |
---|---|
The role of mebendazole in the surgical treatment of central nervous system hydatid disease.
Topics: Adolescent; Adult; Antinematodal Agents; Central Nervous System Diseases; Child; Child, Preschool; C | 1997 |
[Acute trichinellosis with neurological and mental manifestations treated with mebendazol and corticoids (author's transl)].
Topics: Adrenal Cortex Hormones; Adult; Benzimidazoles; Central Nervous System Diseases; Female; Humans; Meb | 1979 |
Chemotherapy of human cystic echinococcosis: comparative efficacy of mebendazole and albendazole.
Topics: Abdomen; Adolescent; Adult; Albendazole; Central Nervous System Diseases; Child; Drug Administration | 1992 |